Inquiries · Recommendations

Recommendations: Infected Blood Inquiry

1,814 tracked recommendations 35 inquiries 103 match current filters Page 1 of 3

Recommendations issued by UK statutory and non-statutory inquiries, with their tracked government response and supporting evidence.

Recommendations

103 of 1,814 · page 1 of 3

Code	Recommendation	Inquiry	Response
AC-1a	Open Registration The scheme be opened to registration to everyone who may be eligible.	Infected Blood Inquiry (2025)	Accepted
AC-1b	Registration and Application Forms There be forms (devised by IBCA) for people to register and apply for a core award and the supplementary awards with/without the …	Infected Blood Inquiry (2025)	Accepted
AC-1c	Legal Support Signposting IBCA include a prominent reference to the availability of legal support paid by IBCA on all registration and application forms and in …	Infected Blood Inquiry (2025)	Accepted
AC-1d	Three-Cohort Prioritisation When IBCA opens up the service beyond people infected and registered with the support schemes, IBCA: (i) update the sequencing to three …	Infected Blood Inquiry (2025)	Accepted
AC-1e	Oral Representations at Review IBCA consider making provision, either generally or in specific cases, for oral representations to be made where a decision is reviewed internally, …	Infected Blood Inquiry (2025)	Accepted
AC-1f	Written Reasons for Decisions Written reasons for the original decision must be provided so that the review process can operate fairly.	Infected Blood Inquiry (2025)	Accepted
AC-2a	Publish Guidance and Board Minutes IBCA should publish: guidance, advice or instructions to claim managers; work undertaken by IBCA with the Cabinet Office's policy team to ensure …	Infected Blood Inquiry (2025)	Accepted
AC-2b	Share Clinical Assessor Advice In respect of any case in which the advice of a clinical assessor has been given, in relation to the person concerned …	Infected Blood Inquiry (2025)	Accepted
AC-2c	Community Advisory Body A formal role be given within IBCA for an advisory body consisting of people infected and affected, covering a range of experience …	Infected Blood Inquiry (2025)	Accepted
AC-2d	Structured Response to Community Input To build confidence that IBCA is actively listening to people infected and affected, IBCA adopt more of a structured response to contributions …	Infected Blood Inquiry (2025)	Accepted
IBI-A-2e	Transparency of Scheme Design The Government and IBCA establish a mechanism by which individuals or organisations may raise concerns which arise about any aspect of the …	Infected Blood Inquiry (2025)	Accepted
IBI-A-3a	HIV Eligibility Start Date An amendment to the Regulations be made as soon as possible to remove the reference to 1 January 1982 from Regulation 3.	Infected Blood Inquiry (2025)	Accepted
IBI-A-4a	Interferon Treatment Impacts People infected with Hepatitis B or C who have received a course of treatment with or based on interferon should be recognised …	Infected Blood Inquiry (2025)	Accepted in Part
IBI-A-4b	Special Category Mechanism The Government reconsider whether to maintain its rejection in February 2025 of the recommendations of Sir Robert Francis KC and advice from …	Infected Blood Inquiry (2025)	Accepted in Part
IBI-A-4c	Effective Treatment - Earnings Floor For the calculation of Financial Loss awards for Hepatitis B, people born after 1953 should be treated like those born in or …	Infected Blood Inquiry (2025)	Accepted
IBI-A-4d	Deeming of Severity Bands Where the level of severity of a person's infection at Level 3 or more has been established to IBCA's satisfaction in relation …	Infected Blood Inquiry (2025)	Accepted
IBI-A-4e	Evidence of Diagnosis Date Regulation 14(2)(c) be amended to remove the requirement for evidence of the date of diagnosis of Hepatitis B or C. An appropriate …	Infected Blood Inquiry (2025)	Accepted
IBI-A-5a	Severe Psychological Harm The approach of the Infected Blood Psychology Service is adopted so that both a diagnosis made by a psychiatric professional and a …	Infected Blood Inquiry (2025)	Accepted in Part
IBI-A-6a	Financial Loss and Care "x" be removed from the equation set out in Regulation 7.	Infected Blood Inquiry (2025)	Accepted in Part
IBI-A-6b	Exceptional Loss Evidence The Cabinet Office consult on whether the evidential requirements for exceptional reduced earnings are likely to prove a barrier to people who …	Infected Blood Inquiry (2025)	Accepted in Part
IBI-A-7a	Unethical Research Award Where there is evidence that an individual was the victim of unethical research practices IBCA should be authorised to make an unethical …	Infected Blood Inquiry (2025)	Accepted in Part
IBI-A-7b	Wider Definition of Unethical Research When considering the evidence IBCA applies the wider definition of research explained in the Infected Blood Inquiry Additional Report chapter on Unethical …	Infected Blood Inquiry (2025)	Accepted in Part
IBI-A-7c	Unethical Research Award Amount Review The Minister consider whether the £10,000 (£15,000 for Treloar's pupils) should in justice be increased and further decides what sum he considers …	Infected Blood Inquiry (2025)	Under Consideration
IBI-A-8a	Supplementary Route for Affected Persons The Minister give consideration to there being a supplementary route for people affected. This could include opening the supplemental award for severe …	Infected Blood Inquiry (2025)	Accepted in Part
IBI-A-8b	Affected Estates The Regulations be amended such that where someone who would be an eligible affected person dies between 21 May 2024 and 31 …	Infected Blood Inquiry (2025)	Accepted
IBI-A-9a	Bereaved Partner Support Scheme The IBSS cut-off date of 31 March 2025 be reviewed, that the scheme should as soon as possible reinstate support payments to …	Infected Blood Inquiry (2025)	Accepted
IBI-1	Compensation Scheme My principal recommendation remains that a compensation scheme should be set up now	Infected Blood Inquiry (2024)	Accepted
IBI-2a	UK and Devolved Memorials A permanent memorial be established in the UK and consideration be given to memorials in each of Northern Ireland, Wales and Scotland. …	Infected Blood Inquiry (2024)	Accepted
IBI-2b	Treloar's School Memorial A memorial be established at public expense, dedicated specifically to the children infected at Treloar’s school. The memorial should be such as …	Infected Blood Inquiry (2024)	Accepted
IBI-2c	Community Support Events There should be at least three events, approximately six months apart, drawing together those infected and affected, the nature and timing of …	Infected Blood Inquiry (2024)	Accepted
IBI-3a	Medical Education - Curriculum The General Medical Council, and NHS Education for Scotland, Health Education and Improvement Wales, Northern Ireland Medical and Dental Training Agency and …	Infected Blood Inquiry (2024)	Accepted
IBI-3b	Medical Education - Training Materials They should look favourably upon putting together a package of training materials, with excerpts from oral and written testimony, to underpin what …	Infected Blood Inquiry (2024)	Accepted
IBI-3c	Inquiry Website Preservation The Inquiry website is maintained online	Infected Blood Inquiry (2024)	Accepted
IBI-4a(i)	Duty of Candour - Northern Ireland Duty of candour: A statutory duty of candour in healthcare should be introduced in Northern Ireland.	Infected Blood Inquiry (2024)	Accepted
IBI-4a(ii)	Duty of Candour - Scotland and Wales Review Duty of candour: The operation of the duties of candour in healthcare in Scotland and in Wales should be reviewed, as it …	Infected Blood Inquiry (2024)	Accepted
IBI-4a(iii)	Duty of Candour - England Review Duty of candour: The review of the duty of candour currently under way in England should be completed as soon as practicable.	Infected Blood Inquiry (2024)	Accepted
IBI-4a(iv)	Individual Duty of Candour for Leaders Statutory duty of candour: The statutory duties of candour in England, Scotland, Wales (and Northern Ireland, when introduced) should be extended to …	Infected Blood Inquiry (2024)	Accepted in Part
IBI-4a(v)	Leadership Accountability for Safety Statutory duty of candour: Individuals in leadership positions should be required by the terms of their appointment and by secondary legislation to …	Infected Blood Inquiry (2024)	Accepted in Part
IBI-4b	Organisational Culture Change Cultural Change: That a culture of defensiveness, lack of openness, failure to be forthcoming, and being dismissive of concerns about patient safety …	Infected Blood Inquiry (2024)	Accepted in Part
IBI-4c(i)	Simplify External Regulation Regulation: That external regulation of safety in healthcare be simplified. As a first step towards this, there should be a UK wide …	Infected Blood Inquiry (2024)	Accepted
IBI-4c(ii)	Safety Management Systems Coordination Regulation: That the national healthcare administrations in England, Northern Ireland, Scotland and Wales explore, and if appropriate, support the development and implementation …	Infected Blood Inquiry (2024)	Accepted
IBI-4d	Patient Records Audit Patient Records: Before the end of 2027 there should be a formal audit, publicly reported, of the extent of success of digitisation …	Infected Blood Inquiry (2024)	Accepted
IBI-4e	Cross-Administration Patient Safety Coordination Coordination of patient records with devolved governments: Consideration should be given by the national healthcare administrations in England, Scotland, Wales and Northern …	Infected Blood Inquiry (2024)	Accepted
IBI-5a	Civil Service Statutory Duty of Candour The Government should reconsider whether, in the light of the facts revealed by this Inquiry, it is sufficient to continue to rely …	Infected Blood Inquiry (2024)	Accepted in Part
IBI-5b	Monitoring Non-Statutory Duties If, on review, the Government considers that it is sufficient to rely on the current non-statutory duties in the Civil Service Code, …	Infected Blood Inquiry (2024)	Accepted in Part
IBI-5c	Ministerial Duty of Candour The Government should consider the extent to which Ministers should be subject to a duty beyond their current duty to Parliament under …	Infected Blood Inquiry (2024)	Accepted in Part
IBI-6a(i)	Hepatologist Oversight and Fibroscan Access All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those who have been …	Infected Blood Inquiry (2024)	Accepted
IBI-6a(ii)	Specialist Hepatology Centre Access All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those who have fibrosis …	Infected Blood Inquiry (2024)	Accepted in Part
IBI-6a(iii)	Uncertainty About Fibrosis All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Where there is any …	Infected Blood Inquiry (2024)	Accepted
IBI-6a(iv)	Fibroscan for Liver Imaging All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Fibroscan technology should be …	Infected Blood Inquiry (2024)	Accepted

Page 1 of 3 Next ›